{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:59:28Z","timestamp":1787497168624,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772933"],"award-info":[{"award-number":["81772933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472572"],"award-info":[{"award-number":["81472572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Program on Key Research Project of China","award":["2016YFC0902700"],"award-info":[{"award-number":["2016YFC0902700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1144-9","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T09:03:47Z","timestamp":1554714227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression"],"prefix":"10.1186","volume":"38","author":[{"given":"Xiaoning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI82066","volume":"126","author":"ML Hedberg","year":"2016","unstructured":"Hedberg ML, Goh G, Chiosea SI, Bauman JE, Freilino ML, Zeng Y, et al. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. J Clin Invest. 2016;126:169\u201380.","journal-title":"J Clin Invest"},{"key":"1144_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.stem.2017.02.003","volume":"20","author":"D Chen","year":"2017","unstructured":"Chen D, Wu M, Li Y, Chang I, Yuan Q, Ekimyan-Salvo M, et al. Targeting BMI1(+) Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma. Cell Stem Cell. 2017;20:621\u201334.e6.","journal-title":"Cell Stem Cell"},{"key":"1144_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2010.12.017","volume":"144","author":"H Douglas","year":"2011","unstructured":"Douglas H, Weinberg Robert A. Hallmarks of Cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell."},{"key":"1144_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1475-2867-14-41","volume":"14","author":"G Kharaishvili","year":"2014","unstructured":"Kharaishvili G, Simkova D, Bouchalova K, Gachechiladze M, Narsia N, Bouchal J. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int. 2014;14:41.","journal-title":"Cancer Cell Int"},{"key":"1144_CR5","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/cancers7040902","volume":"7","author":"K Shiga","year":"2015","unstructured":"Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H. Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth. Cancers (Basel). 2015;7:2443\u201358.","journal-title":"Cancers (Basel)"},{"key":"1144_CR6","doi-asserted-by":"publisher","first-page":"6843","DOI":"10.1158\/0008-5472.CAN-13-1791","volume":"73","author":"V Luga","year":"2013","unstructured":"Luga V, Wrana JL. Tumor-stroma interaction: revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis. Cancer Res. 2013;73:6843\u20137.","journal-title":"Cancer Res"},{"key":"1144_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","volume":"32","author":"V Kumar","year":"2017","unstructured":"Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell. 2017;32:654\u201368.e5.","journal-title":"Cancer Cell"},{"key":"1144_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10(+) GPR77(+) Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841\u201356.e16.","journal-title":"Cell"},{"key":"1144_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.7150\/thno.22182","volume":"8","author":"X Qin","year":"2018","unstructured":"Qin X, Yan M, Wang X, Xu Q, Wang X, Zhu X, et al. Cancer-associated fibroblast-derived IL-6 promotes head and neck Cancer progression via the Osteopontin-NF-kappa B signaling pathway. Theranostics. 2018;8:921\u201340.","journal-title":"Theranostics."},{"key":"1144_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mam.2017.11.011","volume":"60","author":"L Cheng","year":"2018","unstructured":"Cheng L, Zhao WT, Hill AF. Exosomes and their role in the intercellular trafficking of normal and disease associated prion proteins. Mol Asp Med. 2018;60:62\u20138.","journal-title":"Mol Asp Med"},{"key":"1144_CR11","doi-asserted-by":"publisher","first-page":"e10250","DOI":"10.7554\/eLife.10250","volume":"5","author":"H Zhao","year":"2016","unstructured":"Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife. 2016;5:e10250.","journal-title":"eLife."},{"key":"1144_CR12","doi-asserted-by":"publisher","first-page":"11150","DOI":"10.1038\/ncomms11150","volume":"7","author":"CL Au Yeung","year":"2016","unstructured":"Au Yeung CL, Co NN, Tsuruga T, Yeung TL, Kwan SY, Leung CS, et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun. 2016;7:11150.","journal-title":"Nat Commun"},{"key":"1144_CR13","doi-asserted-by":"publisher","first-page":"e2312","DOI":"10.1038\/cddis.2016.224","volume":"7","author":"S Baroni","year":"2016","unstructured":"Baroni S, Romero-Cordoba S, Plantamura I, Dugo M, D'Ippolito E, Cataldo A, et al. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell Death Dis. 2016;7:e2312.","journal-title":"Cell Death Dis"},{"key":"1144_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527:100\u20134.","journal-title":"Nature."},{"key":"1144_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3410\/B3-15","volume":"3","author":"C Thery","year":"2011","unstructured":"Thery C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011;3:15.","journal-title":"F1000 Biol Rep"},{"key":"1144_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1476-4598-13-121","volume":"13","author":"J Yu","year":"2014","unstructured":"Yu J, Xie F, Bao X, Chen W, Xu Q. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting twist in human epithelial cancer. Mol Cancer. 2014;13:121.","journal-title":"Mol Cancer"},{"key":"1144_CR17","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1038\/onc.2014.259","volume":"34","author":"J Zhang","year":"2015","unstructured":"Zhang J, Qin X, Sun Q, Guo H, Wu X, Xie F, et al. Transcriptional control of PAX4-regulated miR-144\/451 modulates metastasis by suppressing ADAMs expression. Oncogene. 2015;34:3283\u201395.","journal-title":"Oncogene."},{"key":"1144_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41467-017-02583-0","volume":"9","author":"T Fang","year":"2018","unstructured":"Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9:191.","journal-title":"Nat Commun"},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/onc.2017.100","volume":"36","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zeng C, Zhan Y, Wang H, Jiang X, Li W. Aberrant low expression of p85alpha in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b. Oncogene. 2017;36:4692\u2013705.","journal-title":"Oncogene."},{"key":"1144_CR20","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/onc.2016.353","volume":"36","author":"KE Richards","year":"2017","unstructured":"Richards KE, Zeleniak AE, Fishel ML, Wu J, Littlepage LE, Hill R. Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene. 2017;36:1770\u20138.","journal-title":"Oncogene."},{"key":"1144_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","volume":"20","author":"X Qin","year":"2019","unstructured":"Qin X, Guo H, Wang X, Zhu X, Yan M, Wang X, et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol. 2019;20:12.","journal-title":"Genome Biol"},{"key":"1144_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2017.03.004","volume":"397","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Li X, Sun W, Yue S, Yang J, Li J, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Lett. 2017;397:33\u201342.","journal-title":"Cancer Lett"},{"key":"1144_CR23","doi-asserted-by":"publisher","first-page":"20587","DOI":"10.1038\/srep20587","volume":"6","author":"X Qin","year":"2016","unstructured":"Qin X, Yan M, Zhang J, Wang X, Shen Z, Lv Z, et al. TGF\u03b23-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis. Sci Rep. 2016;6:20587.","journal-title":"Sci Rep"},{"key":"1144_CR24","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","volume":"35","author":"MB Dinkins","year":"2014","unstructured":"Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:1792\u2013800.","journal-title":"Neurobiol Aging"},{"key":"1144_CR25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ymthe.2017.03.021","volume":"25","author":"AJ O'Loughlin","year":"2017","unstructured":"O'Loughlin AJ, Mager I, de Jong OG, Varela MA, Schiffelers RM, El Andaloussi S, et al. Functional delivery of lipid-conjugated siRNA by extracellular vesicles. Mol Ther. 2017;25:1580\u20137.","journal-title":"Mol Ther"},{"key":"1144_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654\u20139.","journal-title":"Nat Cell Biol"},{"key":"1144_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.oraloncology.2017.11.024","volume":"76","author":"Y Wang","year":"2018","unstructured":"Wang Y, Qin X, Zhu X, Chen W, Zhang J, Chen W. Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway. Oral Oncol. 2018;76:34\u201341.","journal-title":"Oral Oncol"},{"key":"1144_CR28","first-page":"940","volume":"2012","author":"AV Vlassov","year":"1820","unstructured":"Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 1820;2012:940\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"1144_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","volume":"29","author":"L Qu","year":"2016","unstructured":"Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, et al. Exosome-transmitted lncARSR promotes Sunitinib resistance in renal Cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29:653\u201368.","journal-title":"Cancer Cell"},{"key":"1144_CR30","doi-asserted-by":"publisher","first-page":"e2312","DOI":"10.1038\/cddis.2016.224","volume":"7","author":"S Baroni","year":"2016","unstructured":"Baroni S, Romero-Cordoba S, Plantamura I, Dugo M, D\u2019Ippolito E, Cataldo A, et al. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell Death Dis. 2016;7:e2312.","journal-title":"Cell Death Dis"},{"key":"1144_CR31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41467-018-03348-z","volume":"9","author":"AM Givel","year":"2018","unstructured":"Givel AM, Kieffer Y, Scholer-Dahirel A, Sirven P, Cardon M, Pelon F, et al. miR200-regulated CXCL12beta promotes fibroblast heterogeneity and immunosuppression in ovarian cancers. Nat Commun. 2018;9:1056.","journal-title":"Nat Commun"},{"key":"1144_CR32","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/cdd.2017.87","volume":"24","author":"SJ Zhou","year":"2017","unstructured":"Zhou SJ, Deng YL, Liang HF, Jaoude JC, Liu FY. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and notch signaling in hepatocellular carcinoma. Cell Death Differ. 2017;24:1577\u201387.","journal-title":"Cell Death Differ"},{"key":"1144_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3727\/096504017X14953948675421","volume":"26","author":"X Chen","year":"2018","unstructured":"Chen X, Chen J. MiR-3188 regulates cell proliferation, apoptosis, and migration in breast Cancer by targeting TUSC5 and regulating the p38 MAPK signaling pathway. Oncol Res. 2018;26:363\u201372.","journal-title":"Oncol Res."},{"key":"1144_CR34","doi-asserted-by":"publisher","first-page":"11309","DOI":"10.1038\/ncomms11309","volume":"7","author":"M Zhao","year":"2016","unstructured":"Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q, et al. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K\/AKT-c-JUN. Nat Commun. 2016;7:11309.","journal-title":"Nat Commun"},{"key":"1144_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/2159-8290.CD-15-0011","volume":"5","author":"AN Hata","year":"2015","unstructured":"Hata AN, Engelman JA, Faber AC. The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 2015;5:475\u201387.","journal-title":"Cancer Discov."},{"key":"1144_CR36","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1158\/2159-8290.CD-17-0797","volume":"7","author":"JD Leverson","year":"2017","unstructured":"Leverson JD, Sampath D, Souers AJ, Rosenberg SH, Fairbrother WJ, Amiot M, et al. Found in translation: how preclinical research is guiding the clinical development of the BCL2-selective inhibitor Venetoclax. Cancer Discov. 2017;7:1376\u201393.","journal-title":"Cancer Discov"},{"key":"1144_CR37","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ccell.2015.04.010","volume":"27","author":"B Han","year":"2015","unstructured":"Han B, Park D, Li R, Xie M, Owonikoko TK, Zhang G, et al. Small-molecule Bcl2 BH4 antagonist for lung Cancer therapy. Cancer Cell. 2015;27:852\u201363.","journal-title":"Cancer Cell"},{"key":"1144_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1158\/2159-8290.CD-18-1151","volume":"9","author":"GJ Lindeman","year":"2019","unstructured":"Lindeman GJ, Lok SW, Whittle JR, Vaillant F, Teh CE, Lo LL, et al. A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer. Cancer Discov. 2019;9:354\u201369.","journal-title":"Cancer Discov."},{"key":"1144_CR39","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.clinbiochem.2016.04.010","volume":"49","author":"AI Giotakis","year":"2016","unstructured":"Giotakis AI, Kontos CK, Manolopoulos LD, Sismanis A, Konstadoulakis MM, Scorilas A. High BAX\/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis. Clin Biochem. 2016;49:890\u20136.","journal-title":"Clin Biochem"},{"key":"1144_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.oraloncology.2013.10.018","volume":"50","author":"C Moreno-Galindo","year":"2014","unstructured":"Moreno-Galindo C, Hermsen M, Garc\u00eda-Pedrero JM, Fresno MF, Su\u00e1rez C, Rodrigo JP. p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas. Oral Oncol. 2014;50:128\u201334.","journal-title":"Oral Oncol"},{"key":"1144_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1089\/gtmb.2017.0180","volume":"21","author":"LP Agostini","year":"2017","unstructured":"Agostini LP, Stur E, Garcia FM, Ventorim DP, Dos Reis RS, Dettogni RS, et al. ATM, BCL2, and TGFbeta gene polymorphisms as radiotherapy outcome biomarkers in head and neck squamous cell carcinoma patients. Genet Test Mol Biomarkers. 2017;21:727\u201335.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1144_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4161\/cam.5.1.13175","volume":"5","author":"H Ke","year":"2011","unstructured":"Ke H, Zhang JY, Akiyama SK, French JE. BCL2 interaction with actin in vitro may inhibit cell motility by enhancing actin polymerization. Cell Adhes Migr. 2011;5:6\u201310.","journal-title":"Cell Adhes Migr"},{"key":"1144_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1479-5876-3-10","volume":"3","author":"B Escudier","year":"2005","unstructured":"Escudier B, Dorval T, Chaput N, Andre F, Caby MP, Novault S, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med. 2005;3:10.","journal-title":"J Transl Med"},{"key":"1144_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1479-5876-3-9","volume":"3","author":"MA Morse","year":"2005","unstructured":"Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 2005;3:9.","journal-title":"J Transl Med"},{"key":"1144_CR45","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/mt.2008.1","volume":"16","author":"S Dai","year":"2008","unstructured":"Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782\u201390.","journal-title":"Mol Ther"},{"key":"1144_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.28735","volume":"65","author":"L Li","year":"2017","unstructured":"Li L, Piontek K, Ishida M, Fausther M, Dranoff JA, Fu R, et al. Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model. Hepatology. 2017;65:501\u201314.","journal-title":"Hepatology."},{"key":"1144_CR47","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498\u2013503.","journal-title":"Nature."}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1144-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T19:24:55Z","timestamp":1586201095000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1144-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1144-9","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with Good Clinical Practice Guidelines and the Declaration of Helsinki. The study was also approved by the Ethics Committee of Ninth People\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University, and a written informed consent was obtained from all patients.Animal welfare and experimental procedures were conducted in compliance with the Guide for Care and Use of Laboratory Animals (The Ministry of Science and Technology of China, 2006) and the related ethical regulations of the hospital. The Animal Care and Use Committees of the hospital approved all experimental procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"151"}}